Skip to main navigation Skip to search Skip to main content

Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial

  • Juan P. Frías
  • , Samer Nakhle
  • , James A. Ruggles
  • , Sergey Zhuplatov
  • , Eric Klein
  • , Rong Zhou
  • , Poul Strange
  • National Research Institute, Los Angeles, California, USA.
  • Palm Medical Research, Las Vegas, Nevada, USA.
  • AstraZeneca
  • Capital Clinical Research Center, Olympia, Washington, USA.
  • Medpace
  • Princeton University

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalDiabetes, Obesity and Metabolism
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Disciplines

  • Endocrinology
  • Medicine and Health Sciences
  • Gastroenterology
  • Internal Medicine

Cite this